Ether Pharmaceuticals Private Limited
About Ether Pharmaceuticals Private Limited
Data last updated:
Ether Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2019PTC352610. Its GSTIN is 07AAFCE5668J1Z8 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Pulkit Katyal and Ajay Kumar Ahuja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 44 Dsidc Complex Jhilmil Colony, Delhi, India – 110095.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.81 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹10.57 Lakh (net margin 0.4%) and EBITDA of ₹14.27 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 76% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address44 Dsidc Complex Jhilmil Colony, Delhi, India – 110095
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ether Pharmaceuticals Private Limited
The main business activity of Ether Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ether Pharmaceuticals Private Limited FY 2025 filings available
Ether Pharmaceuticals Private Limited reported revenue of ₹25.81 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ether Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 76% over five years, including 24% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ether Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.27 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.57 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ether Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ether Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ether Pharmaceuticals Private Limited
Ether Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Servocare Lifesciences Private Limited | ₹25.93 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Chandigarh, India |
| Medigraph Pharmaceuticals Private Limited | ₹25.9 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Asle Pharmaceuticals Private Limited | ₹25.9 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Jaipur, Rajasthan, India |
| Dasham Medicare Private Limited | ₹25.85 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Malda, West Bengal, India |
| Darwin Platform Pharmaceuticals Limited | ₹25.84 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Ether Pharmaceuticals Private Limited this company | ₹25.81 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Delhi, India |
| Ravenbhel Pharmaceuticals Private Limited | ₹25.73 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Amritsar, Punjab, India |
| Traxo Medserve Private Limited | ₹25.73 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Ahmedabad, Gujarat, India |
| Krishaa Biotech Private Limited | ₹25.7 Cr (FY 2018) | •••• | •••• | 24.0% | •••• | Kolkata, West Bengal, India |
| El-Dorado Biotech Private Limited | ₹25.63 Cr (FY 2025) | •••• | •••• | 64.0% | •••• | Aurangabad, Maharashtra, India |
| Asston Pharmaceuticals Limited | ₹25.61 Cr (FY 2025) | •••• | •••• | 57.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ether Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Ether Pharmaceuticals Private Limited
Ether Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pulkit Katyal | Director | 15 Jul 2019 | 7 Years 2 Months | Current |
| Ajay Kumar Ahuja | Director | 15 Jul 2019 | 7 Years 2 Months | Current |
| Keshav Ahuja | Director | 04 Jul 2024 | 2 Years 3 Months | Current |
Ownership and Shareholding of Ether Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ether Pharmaceuticals Private Limited
Ether Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ether Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ether Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ether Pharmaceuticals Private Limited
Ether Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Keshav Ahuja was appointed as Director on 04 Jul 2024.
Credit Ratings, Litigation & Regulatory Alerts for Ether Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ether Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ether Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ether Pharmaceuticals Private Limited
Ether Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCE5668J1Z8 | Delhi | Active | 08 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ether Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ether Pharmaceuticals Private Limited
Ether Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 July 2019 (7+ years old) and is registered under CIN U51397DL2019PTC352610.
Ether Pharmaceuticals reported revenue of ₹25.81 Cr for FY 2025 (up 24% YoY).
Ether Pharmaceuticals has 3 current directors:
- Pulkit Katyal - Director
- Ajay Kumar Ahuja - Director
- Keshav Ahuja - Director
Ether Pharmaceuticals reported a net profit of ₹10.57 Lakh (net margin 0.4%) and EBITDA of ₹14.27 Lakh (EBITDA margin 0.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ether Pharmaceuticals is 9% over three years and 76% over five years. In the latest year (FY 2025) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ether Pharmaceuticals is 07AAFCE5668J1Z8, registered in Delhi.
The CIN (Corporate Identification Number) of Ether Pharmaceuticals is U51397DL2019PTC352610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ether Pharmaceuticals was incorporated on 15 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ether Pharmaceuticals by revenue are Servocare Lifesciences Private Limited, Medigraph Pharmaceuticals Private Limited, Asle Pharmaceuticals Private Limited, Dasham Medicare Private Limited, Darwin Platform Pharmaceuticals Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Keshav Ahuja was appointed as Director on 04 Jul 2024. Ajay Kumar Ahuja was appointed as Director on 15 Jul 2019. Pulkit Katyal was appointed as Director on 15 Jul 2019.
The registered office of Ether Pharmaceuticals is at 44 Dsidc Complex Jhilmil Colony, Delhi, India – 110095.